| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/16/2005 | EP1506009A2 Glucan-based vaccines |
| 02/16/2005 | EP1506004A2 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac |
| 02/16/2005 | EP1506003A1 Soluble formulations comprising insulin aspart and insulin detemir |
| 02/16/2005 | EP1506002A2 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
| 02/16/2005 | EP1506001A2 Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions |
| 02/16/2005 | EP1506000A1 Heterocyclicsulfonamide hepatitis c virus inhibitors |
| 02/16/2005 | EP1505999A1 Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target |
| 02/16/2005 | EP1505984A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 02/16/2005 | EP1505963A1 Hepatitis c virus inhibitors |
| 02/16/2005 | EP1505945A2 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 02/16/2005 | EP1505943A1 Allograft bone composition having a gelatin binder |
| 02/16/2005 | EP1505942A2 Pathogen vaccines and methods for using the same |
| 02/16/2005 | EP1505873A2 Universal chimera bank |
| 02/16/2005 | EP1425582A4 Diagnostic markers for ischemia |
| 02/16/2005 | EP1337629A4 Dipeptidyl peptidases |
| 02/16/2005 | EP1294741B1 Dipeptide inhibitors for the blood-clotting factor xa |
| 02/16/2005 | EP1246792A4 Compounds and compositions for delivering active agents |
| 02/16/2005 | EP1207898B1 Treatment of conjunctivitis by histacalin proteins |
| 02/16/2005 | EP1037906B1 Cyclopeptide derivatives with integrin inhibitor properties |
| 02/16/2005 | EP0957926B1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 02/16/2005 | EP0846160B1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 02/16/2005 | EP0763360B1 Use of thrombomodulin for treating liver injury |
| 02/16/2005 | EP0656767B1 Composition for regenerating articular cartilage |
| 02/16/2005 | EP0634896B1 Evaluation of patients with progressive immunosuppression |
| 02/16/2005 | CN1582337A 丙型肝炎病毒疫苗 Hepatitis C Virus Vaccine |
| 02/16/2005 | CN1582336A Moraxella (branhamella) catarrhalis antigens |
| 02/16/2005 | CN1582302A Dermopharmaceutically and cosmetically active oligopeptides |
| 02/16/2005 | CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/16/2005 | CN1582296A Template-fixed peptidomimeticsas inhibitors of serine proteases |
| 02/16/2005 | CN1582295A Novel epidermal growth factor protein and gene, and methods of use therefor |
| 02/16/2005 | CN1582178A Hematopoietic stem cell gene therapy |
| 02/16/2005 | CN1582171A Pulmonary administration of chemically modified insulin |
| 02/16/2005 | CN1582168A Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 02/16/2005 | CN1582166A Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 02/16/2005 | CN1582164A Antigen arrays for treatment of bone disease |
| 02/16/2005 | CN1582163A Method of administering a thymosin alpha 1 peptide |
| 02/16/2005 | CN1582162A Thymosin alpha 1 peptide/polymer conjugates |
| 02/16/2005 | CN1582161A Pharmatceutical Formualtion comprising cyclosporin and use thereof |
| 02/16/2005 | CN1582152A composition of estrogen and other hormons with ascorbate, lysine, proline and other substances |
| 02/16/2005 | CN1582149A Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels |
| 02/16/2005 | CN1582146A Methods of inducing ovulation usig non-polypeptide adenosin phosphate level modulator |
| 02/16/2005 | CN1582143A Pro-micelle pharmaceutical compositions |
| 02/16/2005 | CN1580265A T-20 fusion protein, and its preparing method and use |
| 02/16/2005 | CN1580264A High soluble expressed tricholsanthin mutant and its preparing method |
| 02/16/2005 | CN1580262A Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 02/16/2005 | CN1580074A Bean-potato antitumour protein |
| 02/16/2005 | CN1579547A Compound clostridiopeptidase compound emulsion and preparation method |
| 02/16/2005 | CN1579546A Isulin solid granular, its preparation method and its use in preparing medicine for treating diabetes |
| 02/16/2005 | CN1579545A Use of regenerated human interferon beta-1b for preparing medicine to prevent and treat SARS |
| 02/16/2005 | CN1579544A Sucking tablet for promoting liver cell to growth |
| 02/16/2005 | CN1579543A Injection cerebrogalactoside carnosine and its preparing process |
| 02/16/2005 | CN1579542A Lugua polypeptides for injection and its preparing process |
| 02/16/2005 | CN1579541A Compound bone peptide for injection and its preparation process |
| 02/16/2005 | CN1579540A Gugua polypeptides for injection and its preparing method |
| 02/16/2005 | CN1579539A Thymic hormone beta 15 to promote wound healing and generation of blood |
| 02/16/2005 | CN1579538A Garlic protein zymolysis serial product and its preparation method and use |
| 02/16/2005 | CN1579537A Thymic peptide infusion and preparation process |
| 02/16/2005 | CN1579536A Method for preparing anti-hepatitis-B humanbody placenta transfer factor powder injecta |
| 02/16/2005 | CN1579420A Veal-blood protein-removed extract infusion and its preparation process |
| 02/16/2005 | CN1579253A Amino-acid salt drink and amino-acid salt tonic |
| 02/16/2005 | CN1189564C Modulators of the function of receptors of the TNF/NGF receptor family |
| 02/16/2005 | CN1189562C Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 02/16/2005 | CN1189560C Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 02/16/2005 | CN1189482C Novel angiogenesis inhibitor |
| 02/16/2005 | CN1189481C Human truncated recombination soluble TRAIL-170 protein and application for preparing tumour-curing medicine thereof |
| 02/16/2005 | CN1189479C Use of leptin in inhibition of endothelial cell proliferation |
| 02/16/2005 | CN1189478C Cyclic compound |
| 02/16/2005 | CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 02/16/2005 | CN1189476C New thrombin inhibitors, their preparation and use |
| 02/16/2005 | CN1189216C Pharmaceutical compositions containing plasma protein |
| 02/16/2005 | CN1189215C Composition and formulation for solubilizing multiple compounds and preparation method thereof |
| 02/16/2005 | CN1189212C Mixed preparation for enhancing physical cancer cell chemical theray sensitirity |
| 02/16/2005 | CN1189211C Therapeutic methods and compsns. for treatment of in paired interpersonal and behavioral disorders |
| 02/16/2005 | CN1189210C Coupling object between CB and biological active peptide as well as medication usage thereof |
| 02/16/2005 | CN1189209C Application of osteogenic growth peptide in promoting bematogenesis |
| 02/16/2005 | CN1189168C Use of (-)-(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2-diabetes, hyperlipidemia and hyperuricemia |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/15/2005 | US6855860 Nonocclusive dressing comprising natural polymer fibers and a synthetic polymer foam layer having a pore-containing surface physically interlocked with the fibers; separation; nonadhesive; easy to manufacture; nontoxic; permeability |
| 02/15/2005 | US6855815 Introducing a nucleic acid to a host cell, growing host cell to express nucleic acid as a transcript and such transcript is expressed as a translation product containing cellular inhibitor of apoptosis protein |
| 02/15/2005 | US6855812 P-glycoproteins and uses thereof |
| 02/15/2005 | US6855811 Polypeptide for use in the treatment of diagnosis, treatment, and prevention of cell proliferative and immune defects |
| 02/15/2005 | US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof |
| 02/15/2005 | US6855808 Prevent cell differentiation; culture product; genetic engineered protein |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855805 α-conotoxin peptides |
| 02/15/2005 | US6855803 Protein having hemolytic activity and gene encoding the protein |
| 02/15/2005 | US6855802 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy |
| 02/15/2005 | US6855801 Peptides modulating activities of heparin other glycosaminoglycans or proteoglycans |
| 02/15/2005 | US6855700 Antisense modulation of damage-specific DNA binding protein 1, p127 expression |
| 02/15/2005 | US6855696 Antitumor agents |
| 02/15/2005 | US6855695 Water-soluble SHPs as novel alkylating agents |
| 02/15/2005 | US6855694 Prophylaxis of nervous system disorders comprising administering ubiquitin and liver extracts |
| 02/15/2005 | US6855693 Peptide for use in the treatment of cell damage caused by ischemia |
| 02/15/2005 | US6855692 Histogranin peptides and their analgesic use |
| 02/15/2005 | US6855691 Methods for producing and using S-nitrosohemoglobins |
| 02/15/2005 | US6855690 Treating with oncomodulin protein |
| 02/15/2005 | US6855689 Anticancer agents |
| 02/15/2005 | US6855688 ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of use |
| 02/15/2005 | US6855687 Administering to the site in need of cartilage repair a polypeptide having the sequence Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Cys-Glu-Gl y-Asp-Ser-Pro-Phe-Val |
| 02/15/2005 | US6855686 Also administering to the subject an effective amount of an mda-7 protein. |